Regulation - Alkermes, Pharmaceutical

Filter

Current filters:

AlkermesPharmaceutical

Popular Filters

FDA approves Otsuka and Lundbeck's once-monthly Abilify Maintena for schizophrenia

01-03-2013

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) and Danish partner Lundbeck (LUND: DC) have received…

Abilify MaintenaAlkermesLundbeckNeurologicalNorth AmericaOtsukaPharmaceuticalRegulation

Alkermes pulls MAA for Megestrol product

13-03-2012

The European Medicines Agency says it has been formally notified by the Irish subsidiary of US drugmaker…

AlkermesAnti-viralsEuropeMegestrolOncologyPharmaceuticalRegulation

FDA finally approves Bydureon

30-01-2012

There was good news on Friday for USA-based Amylin Pharmaceuticals (Nasdaq: AMLN) and Alkermes (Nasdaq:…

AlkermesAmylinBydureonDiabetesEli LillyNorth AmericaPharmaceuticalRegulation

Back to top